19. DEREJKO, M.; SLAWEK, J.; WIECZOREK, D.; et al. Regional cerebral
blood flow in Parkinson’s disease as an indicator of cognitive impairment.
Nuclear Medicine Communications, v. 27, n. 12, p. 945-951, 2006.
20. ELLIS, T.; GOEDE, C. J.; FELDMAN, R. G.; WOLTERS, E. C.; KWAKKEL,
G,; WAGENAAR, R. C. Efficacy of a physical therapy program in patients with
Parkinson’s disease: A randomized controlled trial. Archives of Physical
Medicine and Rehabilitation, v. 86, n. 4, p. 626-632, 2005.
21. FAHN, S. Description of Parkinson's disease as a clinical syndrome. Annals
of the New York Academy of Sciences, v. 991, p. 1-14, 2003.
22. FAHN, S.; MARSDEN, C. D.; CALNE, D. B.; GODSTEIN, M. Recent
developments in Parkinson’s disease. Macmilla Health Care Information, v. 2,
p. 153-164, 1987.
23. FEARNLEY, J. M.; LEES, A. J. Aging and Parkinson’s disease: substantia
nigra regional selectivity. Brain, v. 114, p. 2283-2301, 1991.
24. FERRAZ, H. B.; BORGES, V. Doença de Parkinson. Revista Brasileira de
Medicina, v.59, n. 4, p. 207-219, 2002.
25. FIELDING, J.; GEORGIOU-KARISTIANIS, N.; WHITE, O. The role of the
basal ganglia in the control of automatic visuospatial attention. Journal of the
International Neuropsychological Society, v. 12, p. 657-667, 2006.
26. GALLETLY, R.; BRAUER, S. G. Does the type of concurrent task affect
preferred and cued gait in people with Parkinson’s disease? The Australian
Journal of Physiotherapy, v. 51, n. 3, p. 175-180.
27. GRANDAS, F.; IRANZO, A. Nocturnal problems occurring in Parkinson’s
disease. Neurology, v. 63, n. 8 Suppl. 3, p. S8-11, 2004.
28. GROSSMAN, M.; GLOSSER, G.; KALMANSON, J.; et al. Dopamine
supports sentence comprehension in Parkinson’s disease. Journal of the
Neurological Sciences, v. 184, p. 123-130, 2001.
29. GURD, J. M.; MASTER, N.; OLIVEIRA, R. M. A method for investigating the
relation between cognitive and motor functions in Parkinson’s disease. Journal
of Neurolinguistics, v. 14, p. 45-57, 2001.